Arteris (NASDAQ:AIP - Get Free Report) was downgraded by equities researchers at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued to clients and investors on Friday.
A number of other research analysts have also recently commented on AIP. TD Cowen raised their price target on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Rosenblatt Securities restated a "buy" rating and issued a $14.00 price target on shares of Arteris in a research report on Wednesday, May 21st. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, Arteris presently has an average rating of "Buy" and a consensus target price of $15.00.
Get Our Latest Research Report on Arteris
Arteris Trading Up 0.9%
AIP stock traded up $0.09 during trading hours on Friday, hitting $9.79. 153,872 shares of the stock were exchanged, compared to its average volume of 2,167,098. The firm has a market capitalization of $417.54 million, a P/E ratio of -11.94 and a beta of 1.45. The company has a 50-day simple moving average of $9.53 and a two-hundred day simple moving average of $8.27. Arteris has a 12 month low of $5.46 and a 12 month high of $14.29.
Arteris (NASDAQ:AIP - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). The firm had revenue of $16.50 million for the quarter, compared to analysts' expectations of $16.35 million. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities research analysts predict that Arteris will post -0.73 earnings per share for the current year.
Insider Activity
In other news, CFO Nicholas B. Hawkins sold 11,276 shares of Arteris stock in a transaction dated Tuesday, August 5th. The stock was sold at an average price of $13.15, for a total transaction of $148,279.40. Following the sale, the chief financial officer directly owned 107,996 shares of the company's stock, valued at approximately $1,420,147.40. This trade represents a 9.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO K Charles Janac sold 94,245 shares of Arteris stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $13.49, for a total value of $1,271,365.05. Following the sale, the chief executive officer directly owned 189,785 shares in the company, valued at $2,560,199.65. The trade was a 33.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 456,043 shares of company stock valued at $5,484,028. 29.10% of the stock is currently owned by company insiders.
Institutional Trading of Arteris
A number of hedge funds have recently made changes to their positions in AIP. G2 Investment Partners Management LLC acquired a new stake in shares of Arteris during the fourth quarter valued at about $2,799,000. Acadian Asset Management LLC lifted its stake in shares of Arteris by 40.6% in the first quarter. Acadian Asset Management LLC now owns 900,723 shares of the company's stock worth $6,222,000 after acquiring an additional 260,277 shares during the period. AQR Capital Management LLC acquired a new position in shares of Arteris in the first quarter worth approximately $1,621,000. Federated Hermes Inc. lifted its stake in shares of Arteris by 97.2% in the first quarter. Federated Hermes Inc. now owns 327,119 shares of the company's stock worth $2,260,000 after acquiring an additional 161,241 shares during the period. Finally, Franklin Resources Inc. lifted its stake in shares of Arteris by 9.6% in the second quarter. Franklin Resources Inc. now owns 1,637,171 shares of the company's stock worth $15,602,000 after acquiring an additional 142,936 shares during the period. 64.36% of the stock is owned by institutional investors and hedge funds.
Arteris Company Profile
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
See Also
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.